Dabrafenib: all 106 studies that test it
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive TumorsCompletedNCT01738451Phase 1
- Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant TumorsCompletedNCT01713972Phase 1
- A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid TumorsCompletedNCT01582997Phase 1
- A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01340846Phase 1
- Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01340833Phase 1
- An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01262963Phase 1